Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.
- DOI
- 10.1038/s43018-026-01193-4
- Published
- 2026 Jul
- Container
- Nature cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s43018-026-01193-4,
title = {Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.},
author = {Tao YL and Wu DH and Zhou Q and Yang KY and Jin F and Zhu XD and Shi M and Hu GQ and Sun Y and Wu HF and Wu H and Lin Q and Wang H and Tian Y and Zhang N and Wang XC and Shen LF and Liu ZZ and Huang J and Luo XL and Li L and Zang J and Mei Q and Zheng BM and Yue D and Xu J and Wu SG and Chen L and Li WF and Zhou GQ and Sun R and Guo R and Zhang Y and Xu C and Lv JW and Guo Y and Feng HX and Tang LL and Xie FY and Liu X and Sun Y and Ma J and Mao YP and Chen YP},
year = {2026},
journal = {Nature cancer},
doi = {10.1038/s43018-026-01193-4},
url = {https://doi.org/10.1038/s43018-026-01193-4}
}RIS
TY - JOUR TI - Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study. AU - Tao YL AU - Wu DH AU - Zhou Q AU - Yang KY AU - Jin F AU - Zhu XD AU - Shi M AU - Hu GQ AU - Sun Y AU - Wu HF AU - Wu H AU - Lin Q AU - Wang H AU - Tian Y AU - Zhang N AU - Wang XC AU - Shen LF AU - Liu ZZ AU - Huang J AU - Luo XL AU - Li L AU - Zang J AU - Mei Q AU - Zheng BM AU - Yue D AU - Xu J AU - Wu SG AU - Chen L AU - Li WF AU - Zhou GQ AU - Sun R AU - Guo R AU - Zhang Y AU - Xu C AU - Lv JW AU - Guo Y AU - Feng HX AU - Tang LL AU - Xie FY AU - Liu X AU - Sun Y AU - Ma J AU - Mao YP AU - Chen YP PY - 2026 JO - Nature cancer DO - 10.1038/s43018-026-01193-4 UR - https://doi.org/10.1038/s43018-026-01193-4 ER -
APA
YL, T., DH, W., Q, Z., KY, Y., F, J., XD, Z., M, S., GQ, H., Y, S., HF, W., H, W., Q, L., H, W., Y, T., N, Z., XC, W., LF, S., ZZ, L., J, H., XL, L., L, L., J, Z., Q, M., BM, Z., D, Y., J, X., SG, W., L, C., WF, L., GQ, Z., R, S., R, G., Y, Z., C, X., JW, L., Y, G., HX, F., LL, T., FY, X., X, L., Y, S., J, M., YP, M., & YP, C. (2026). Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.. Nature cancer. https://doi.org/10.1038/s43018-026-01193-4
Source records
- pubmed · retrieved 2026-09-27T16:48:31.439Z